Furthermore, in case-only analyses, women with adverse breast cancer features (for example, higher stage or hormone receptor negativity) consistently had lower prevalence of FMc although no single characteristic reached statistical significance because power was limited for such analyses. Here, NR4A1 is linked to breast cancer.